Komori
Olympus (7733) · InitiativeAchieved

Integration of domestic sales functions for the medical and scientific businesses

First written in FY2021-Q3. 1 of 3 entries say "Restated". Latest entry: FY2022-Q2.

3entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021-Q3 – FY20212021: 32021
Same theme, other companies
Integration of domestic sales functions for the medical and scientific businessesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022-Q2AchievedAnnual report

    「On 1 October 2021, the Company carried out a company split under which part of the rights and obligations relating to the domestic sales functions of its endoscopy and therapeutic device businesses changed from the Company to Olympus Medical Science Sales Co., Ltd., a wholly owned subsidiary of the Company.」

    The integration of the domestic sales functions for the endoscopy and therapeutic device businesses was implemented on 1 October 2021, and the sales structure moved to the strengthening phase under Olympus Marketing Co., Ltd.
  2. FY2021RestatedAnnual report

    「By integrating the domestic sales functions of the two companies’ endoscopy and therapeutic device businesses, the Company aims to strengthen its sales structure by achieving flexible workforce allocation, stronger collaboration with partners, nationwide deployment of unified initiatives, and the acquisition and retention of highly talented personnel.」

    The policy of strengthening the sales structure through flexible workforce allocation, nationwide unified initiatives and talent retention was reaffirmed in connection with the integration of the Company’s and OMSJ’s domestic sales functions.
  3. FY2021-Q3First statedAnnual report

    「By integrating the domestic sales functions of the healthcare and scientific businesses of the two companies, the Company aims to strengthen its sales structure by achieving flexible workforce allocation, stronger collaboration with partners, nationwide deployment of unified initiatives, and the acquisition and retention of highly talented personnel.」

    The Company plans to integrate its domestic sales functions with those of OMSJ through a company split, with 1 October 2021 scheduled as the effective date. On the same date, OMSJ plans to change its corporate name to “Olympus Marketing Co., Ltd.”, with the aim of strengthening the flexibility and consistency of its sales structure and securing talent.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Olympus yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Integration of domestic sales functions for the medical and scientific businesses | OLYMPUS CORPORATION (7733) | Komori